Clinical Trial Details
EORTC-62902
Back to Clinical Trials Database
PHASE II STUDY OF DAILY ORAL MILTEFOSINE (HEXADECYLPHOSPHOCHOLINE) IN ADVANCED SOFT TISSUE SARCOMAS OF THE ADULT.
Trial Status | All trial activities ended |
---|---|
Dates |
Date of activation: 14-Jun-1990 Date Step1 close: 15-Mar-1991 |
Data management at EORTC | Yes |
Design |
Phase 2 Randomized open label |
Targeted Sample size | EORTC Groups: 25 |
Treatment | |
Study Staff | |
Type of cancer | |
Participating groups | |
Protocol summary | http://clinicaltrials.gov/study/ |
NCT number |